Surgical Planning Associates, Inc.
$158.3K 28 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
US Implant Solutions, LLC
US Implant Solutions, LLC reported $157,122.73 across General Payments, Research, and Ownership to 162 physicians and teaching hospitals across 162 transactions.
- $157.1K Below-median payer
- All-tracks total
- 162 Above-median volume
- Transactions
- 162 Above-median reach
- Recipients
- +$99.5K
- General Payments vs PY2023
US Implant Solutions, LLC reported $157,122.73 across all CMS Open Payments tracks (General + Research + Ownership) to 162 physicians and teaching hospitals in Program Year 2024 - ranking #1073 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $157,122.73, averaging $969.89 per recipient.
How US Implant Solutions, LLC's $157.1K all-tracks total breaks down
US Implant Solutions, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
18/100
Total payments
F
11/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer us-implant-solutions-llc US Implant Solutions, LLC
$157.1K · #1073/1,925 · 0.0% industry · PY2024
- TOT $157.1K
- RANK #1073
- SHARE 0.0%
- TXN 162
- RCP 162
- CAT 3
- GEN $157.1K
- ΔGEN +$99.5K
- TOP1 10.6%
- PY 2024
Volume peers
Nearest volume peer: Surgical Planning Associates, Inc. ($158.3K)
US Implant Solutions, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
US Implant Solutions, LLC's CMS-reported General Payments increased by $99.5K (+172.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: US IMPLANT SOLUTIONS, LLCPY2023: US IMPLANT SOLUTIONS, LLCPY2024: US Implant Solutions, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $57,622.26
- PY2024
- $157,122.73
What the Data Shows for US Implant Solutions, LLC
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For US Implant Solutions, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Travel and Lodging" at $136.4K, accounting for 86.8% of this company's General Payments and 36 transactions.
General Payment Breakdown by Type
"Travel and Lodging" leads US Implant Solutions, LLC's 3-category general-payment breakdown at $136.4K, 86.8% of the reported total.
How US Implant Solutions, LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $136.4K | 36 | 86.8% |
| Food and Beverage | $17.4K | 125 | 11.1% |
| Consulting Fee | $3.3K | 1 | 2.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $66,812.84 (42.5%) of $157,122.73 in this company's General Payments records across 47 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for US Implant Solutions, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Charles Moon
$16,643.87 across 7 reported transactions
- 2
Daniel Allison
$13,176.35 across 10 reported transactions
- 3
Daniel Horwitz
$12,985.60 across 8 reported transactions
- 4
Hans Van Lancker
$12,615.22 across 7 reported transactions
- 5
Erik Kubiak
$11,391.80 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
US Implant Solutions, LLC's spend rank (#1073 of 1,925, bottom 44% by spend) and concentration rank (#1,200 of 1,838, bottom 35% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- KARL STORZ Endoscopy-America : $1.4M total payments, HHI 655
- Advanced Critical Devices, Inc. : $1.2K total payments, HHI 653
- BioLineRx USA, Inc. : $112.3K total payments, HHI 652
- Cardinal Health 108 LLC : $1.8K total payments, HHI 651
- ADMA BioManufacturing LLC : $167.7K total payments, HHI 650
- Expanding Innovations, Inc. : $130.8K total payments, HHI 649
- US Implant Solutions, LLC (this company) : $157.1K total payments, HHI 646
- Edap Technomed Inc : $640.3K total payments, HHI 644
- PENTAX of America, Inc. : $368.9K total payments, HHI 642
- Bone Support Inc. : $613.3K total payments, HHI 641
- Eagle Pharmaceuticals, Inc. : $177.1K total payments, HHI 640
- EyePoint Pharmaceuticals US, Inc. : $827.8K total payments, HHI 640
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as US Implant Solutions, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about US Implant Solutions, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with US Implant Solutions, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
NX Development Corp.
$158.5K 0 recipients
Compare payment profiles
Theragenics Corporation
$155.5K 65 recipients
Compare payment profiles
Micro-tech Endoscopy USA, Inc.
$159.3K 1,649 recipients
Compare payment profiles
Corcym Inc
$154.4K 495 recipients
Compare payment profiles
Outset Medical Inc
$160.7K 340 recipients
Compare payment profiles
Put this to use
US Implant Solutions, LLC ranks #1073 of 1,925 by all-tracks total payments, led by "Travel and Lodging".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Travel and Lodging" spend across every manufacturer, not just US Implant Solutions, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.